Benitec Biopharma prices $100M stock offering

* Benitec Biopharma (BNTC [https://seekingalpha.com/symbol/BNTC]) priced [https://seekingalpha.com/pr/20295927-benitec-biopharma-inc-announces-pricing-of-100-million-common-stock-offering] its underwritten public offering of ~5.93M shares and a concurrent registered direct offering of ~1.48M shares with long-term investor Suvretta Capital.
* Each share of common stock is being sold at an offering price of $13.50 and the underwriters will have a 30-day option to purchase up to an additional 889,500 shares.
* The offerings are expected to close on November 7, 2025.
* The aggregate gross proceeds to Benitec from the underwritten public offering and the concurrent registered direct offering are expected to be ~$100M.
* Net proceeds, together with existing cash on hand will be used to support the continued development of its product candidate programs, working capital, and other general corporate purposes.
* The stock price dropped 2.7% on Wednesday during after-market hours of trading.

MORE ON BENITEC

* Seeking Alpha’s Quant Rating on Benitec [https://seekingalpha.com/symbol/BNTC/ratings/quant-ratings]
* Historical earnings data for Benitec [https://seekingalpha.com/symbol/BNTC/earnings]
* Financial information for Benitec [https://seekingalpha.com/symbol/BNTC/income-statement]